ALX148
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ALX148, covering 2026-03-04 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]